Avantor, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Avantor, Inc. (AVTR) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-14.
Discontinued › Income Statement
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2020-02-14
- Avantor, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2019 was $0.00.
- Avantor, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2018 was $0.00.
- Avantor, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2017 was -$32.60M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-14 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-14 |
| 2017-12-31 | -$32.60M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |